Skip to main content

PYPD · PolyPid Ltd. · Webcasts, Transcripts & Audio

Track PYPD — free
$5.50 -0.28 (-4.84%) Q2 2026 earnings call transcript
Market Cap
$115.78M
Shares
20.31M
Volume · Oct 29 93.28K Avg daily vol (3M) 118.96K

PolyPid Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for PolyPid Ltd. (PYPD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-11
PolyPid Ltd. (PYPD) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-12
PolyPid Ltd. (PYPD) Q2 2026 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-13
PolyPid Ltd. (PYPD) Q1 2026 Earnings Call Transcript
Confident tone D-PLEX100 NDA Submission and Regulatory Progress FDA Manufacturing Inspection Readiness Cash Runway and Financial Position
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-11
PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript
Confident tone Kynatrix technology platform introduction D-PLEX100 regulatory progress and NDA submission Commercialization readiness and IDN/hospital uptake
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2025 Earnings Call Transcript
Confident tone DPLEX 100 regulatory progress US market access study SHIELD II Phase III data and clinical profile
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2025 Earnings Call Transcript
Confident tone SHIELD II Phase III Results Commercial Partnership Strategy Regulatory Pathway and NDA
Diluted EPS
$0.78
▼ 37.6% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript
Confident tone SHIELD 2 Phase 3 Trial Regulatory Submissions D-PLEX100 Product
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript
Confident tone D-PLEX100 Product Candidate SHIELD II Phase 3 Trial Progress Regulatory Path and NDA
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2024 Earnings Call Transcript
Confident tone SHIELD II Trial Progress and Enrollment D-PLEX100 Product Profile and Publication Interim Analysis Outcome Scenarios
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2024 Earnings Call Transcript
Positive tone SHIELD II trial enrollment and timeline SHIELD I learnings and de-risking Financing and cash runway
Diluted EPS
$1.25
▼ 68.4% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
PolyPid Ltd. (PYPD) Q1 2024 Earnings Call Transcript
Confident tone D-PLEX100 Regulatory and NDA Pathway SHIELD II Phase III Trial Enrollment Progress Patient Demographics and Trial Design Lessons
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
PolyPid Ltd. (PYPD) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2023 Earnings Call Transcript
Diluted EPS
$3.95
▼ 78.4% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
PolyPid Ltd. (PYPD) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
PolyPid Ltd. (PYPD) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2022 Earnings Call Transcript
Diluted EPS
$18.30
▲ 8.9% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
PolyPid Ltd. (PYPD) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
PolyPid Ltd. (PYPD) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2021 Earnings Call Transcript
Diluted EPS
$16.80
▼ 97.8% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
PolyPid Ltd. (PYPD) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
PolyPid Ltd. (PYPD) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Date not confirmed
PolyPid Ltd. (PYPD) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
PolyPid Ltd. (PYPD) Q2 2020 Earnings Call Transcript
Diluted EPS
$759.00
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 webcasts
Key facts CIK 1611842 CUSIP M8001Q126 13F (30d) 3 filings 3 filers Visit website Investor relations